Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
08 November 2021 - 11:27PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR
15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of November, 2021
Commission file number: 001-37891
AC IMMUNE SA
(Exact Name of Registrant as Specified in Its Charter)
|
EPFL Innovation Park
Building B
1015 Lausanne, Switzerland |
|
(Address of Principal Executive Offices) |
Indicate by check mark whether the registrant files or will file
annual reports under cover of Form 20-F or Form 40-F.
Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(1):
Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(7):
This
Report on Form 6-K (excluding Exhibit 99.3 herewith) is
incorporated by reference into the Registrant's registration
statements on Form F-3 (File Nos. 333-227016, 333-249655 and
333-255576) and Form S-8 (File No. 333-233019).
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned, thereunto duly authorized.
|
AC IMMUNE
SA |
|
|
|
|
|
By: |
/s/ Andrea Pfeifer |
|
|
Name: |
Andrea
Pfeifer |
|
|
Title: |
Chief Executive
Officer |
|
By: |
/s/ Joerg Hornstein |
|
|
Name: |
Joerg
Hornstein |
|
|
Title: |
Chief Financial
Officer |
Date: November 8, 2021
EXHIBIT INDEX
Exhibit Number
|
Description
|
99.1 |
Interim Condensed
Consolidated Financial Statements (Unaudited) (IFRS) as of and for
the three and nine months ended September 30, 2021 |
|
|
99.2 |
Management’s
Discussion and Analysis of Financial Condition and Results of
Operations |
|
|
99.3 |
Press Release dated
November 8, 2021 |
|
|
99.4 |
Articles of
Association as of October 21, 2021 |
AC Immune (NASDAQ:ACIU)
Historical Stock Chart
From Apr 2022 to May 2022
AC Immune (NASDAQ:ACIU)
Historical Stock Chart
From May 2021 to May 2022